Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.

The human lympholine osteoclast activating factor (OAF) is thought to be involved in several bone-destroying diseases. The current studies were designed to produce monoclonal antibodies against OAF for use in the subsequent design of immunoassays for OAF in clinical samples. Spleen cells from mice i...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Invest
Egile Nagusiak:	Luben, R A, Mohler, M A, Nedwin, G E
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical Investigation 1979
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/221547/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109459
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!